Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2005
12/14/2005EP1296742B1 Intradermal delivery of substances
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005EP1082103B1 Spill resistant pharmaceutical compositions
12/14/2005CN1708499A Purine compounds and use thereof as cannabinoid receptor ligands
12/14/2005CN1708491A N-benzodioxolyl, N-benzodioxanyl and N-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
12/14/2005CN1708486A Novel heterocyclic analogs of diphenylethylene compounds
12/14/2005CN1708479A Novel compounds useful in treating PPAR mediated diseases
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
12/14/2005CN1708312A New alpha-glucosidase inhibitors from a natural source
12/14/2005CN1708236A Use of pullulan as a slowly digested carbohydrate
12/14/2005CN1231489C Amine salt of lignan compound
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231482C Processes for the preparation of thiazolidinedione derivatives and intermediates
12/14/2005CN1231474C Salts of aiso thiazole-4-carboxamide and their use as anti-hyperproliferatin agents
12/14/2005CN1231466C New piperidine derivatives
12/14/2005CN1231460C Process for the preparation of (R)-or (S)-aminocarnitine inner salt, the salts and derivatives thereof
12/14/2005CN1231262C Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising the same
12/14/2005CN1231227C Making process of nanometer level pearl powder and shell powder
12/14/2005CN1231225C Application of Artemisia sphaerocephala Krasch polysaccharide in preparation of antilipemic agent and health products
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974832 L-ascorbic acid and pectin composition
12/13/2005US6974830 For therapy of atherosclerosis, gallstone disease, lipid disorders, obesity or a cardiovascular disorder
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/13/2005US6974819 Alzheimer's disease; Parkinson's disease; Pick's disease; bipolar disorders; schizophrenia; alopecia; anticancer agents
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/13/2005US6974808 CRF receptor antagonists and methods relating thereto
12/13/2005CA2271054C Substituted phenols and thiophenols useful as antioxidant agents
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/08/2005WO2005116057A1 Monoclonal antibody against abca1
12/08/2005WO2005116018A1 TYROSINE DERIVATIVES SUBSTITUTED BYALKANOYLAS hPPARα & hPPARϜ ANGONISTS
12/08/2005WO2005116012A1 Pyrrolidine derivative
12/08/2005WO2005116005A1 Epigallocatechin dimer and trimer having lipase inhibitory activity and/or antioxidative activity
12/08/2005WO2005116002A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/08/2005WO2005115999A1 Tyrosine derivatives substituted by n-phenylacryloyl as agonists of hppar alpha and hppar gama
12/08/2005WO2005115998A1 TYROSINE DERIVATIVES SUBSTITUTED BY ALKANOYLAS hPPARα & hPPARϜ ANGONISTS
12/08/2005WO2005115993A1 Quinazoline derivative
12/08/2005WO2005115427A1 Herbal medicine composition for suppression of obesity and preparation method thereof
12/08/2005WO2005115425A1 Composition comprising fermented tea extract as the main component and having effect of incrasing adiponectin
12/08/2005WO2005115422A2 Compositions containing avocado leaf extract for lowering cholesterol levels
12/08/2005WO2005115393A1 An anti-hyperlipemia composition
12/08/2005WO2005115378A1 Compositions comprising flavonoids and tocotrienols and methods thereof
12/08/2005WO2005115377A1 Functional foods comprising flavonoids and tocotrienols and methods thereof
12/08/2005WO2005115369A2 Use of ppar agonists to treat ruminants
12/08/2005WO2005115366A1 Agent for preventing/amelioratig life style-relaetd diseases containing turmeric essential oil component
12/08/2005WO2005081649A3 Preparation for reducing protein deficiency in an organism and method for the production thereof
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272915 Skrp, astray, string, vacm associated with metabolic control
12/08/2005US20050272814 Medicine for prevention or treatment of diabetes
12/08/2005US20050272801 Isoprenoid pathway inhibitors for stimulating cartilage growth
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272783 Amino acids with affinity for the alpha2delta-protein
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272767 Method for treating myolytic disease and method for screening antimyolytic agent
12/08/2005US20050272765 Dipeptidyl peptidase inhibitors
12/08/2005US20050272763 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272711 Substance for lowering high cholesterol level in serum and methods for preparing and using the same
12/08/2005US20050272669 treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. -[(4-{3-[N-(Carbamoylmethyl)-N-(methanesulfonyl)amino]-propoxy}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole
12/08/2005US20050272641 Therapeutic agents for diabetes
12/08/2005US20050272639 Crystalline polymorph of the pentahydrate form in synergistic combination with another active ingredient to enhance drug delivery; antidiabetic agents
12/08/2005US20050272148 Method of collecting placental stem cells
12/08/2005US20050272036 Ketones
12/08/2005US20050271744 Comprising a peptide fraction which is preferably rich in di- and tripeptides in combination with an insulin sensitizer, preferably a natural or pharmaceutical insulin sensitizer; suitable as pharmaceutical or food or a food supplement; especially useful for Type 2 diabetes
12/08/2005US20050271717 Dry-granulated dosage forms of tablets or capsules; preparation by compressing the mixture, milling, grinding or sieving the compressed material; hypercholesterolemia, hyperlipidemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's disease
12/08/2005DE10021731B4 Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben Cyclipostins, processes for their preparation and pharmaceutical preparation thereof
12/08/2005CA2586222A1 Enzymes for pharmaceutical use
12/08/2005CA2569081A1 Quinazoline derivative
12/08/2005CA2568578A1 Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof
12/08/2005CA2568547A1 Composition comprising fermented tea extract as the main component and having effect of elevating adiponectin level
12/08/2005CA2568009A1 Use of ppar agonists to treat ruminants
12/08/2005CA2567969A1 Compositions comprising flavonoids and tocotrienols and methods thereof
12/08/2005CA2567963A1 Functional foods comprising flavonoids and tocotrienols and methods thereof
12/08/2005CA2567637A1 Using organic and/or inorganic potassium and its salts to treat autoimmune and other health disorders and methods of administering the same
12/08/2005CA2567398A1 New use
12/08/2005CA2566202A1 Agent for preventing/ameliorating life style-related diseases containing turmeric essential oil component
12/08/2005CA2566154A1 Combination of atomoxetine and a 5t1a receptor agonist for treating adhd and other disorders
12/08/2005CA2564668A1 Pyrrolidine derivatives
12/07/2005EP1602666A1 Novel protein and its dna
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602652A1 Adiponectin expression promoter
12/07/2005EP1602647A1 Novel compound having 4-pyridylalkylthio group as substituent
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1602380A1 Preventive/remedy for diseases in upper digestive tract
12/07/2005EP1602376A1 Preventive/remedy for obesity
12/07/2005EP1602370A2 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
12/07/2005EP1601782A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b)
12/07/2005EP1601671A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament
12/07/2005EP1601669A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/07/2005EP1601668A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/07/2005EP1601666A2 New neuropeptide y y5 receptor antagonists
12/07/2005EP1601352A2 Combined use of a fibrate and orlistat for the treatment of obesity
12/07/2005EP1601346A2 Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method
1 ... 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 ... 1298